PMC:7170415 / 27353-27741 JSONTXT

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T25","span":{"begin":340,"end":345},"obj":"Body_part"}],"attributes":[{"id":"A25","pred":"uberon_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/UBERON_0002542"}],"text":"Critical considerations for diagnostics used for epidemic diseases of public health importance include the quality assurance and regulatory frameworks surrounding testing. Mature regulatory agencies have developed mechanisms to account for emergencies, such as the FDA's EUA stream, but pragmatic solutions must be found to facilitate wide-scale, independent evaluation of emerging tests."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T240","span":{"begin":163,"end":170},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T241","span":{"begin":382,"end":387},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Critical considerations for diagnostics used for epidemic diseases of public health importance include the quality assurance and regulatory frameworks surrounding testing. Mature regulatory agencies have developed mechanisms to account for emergencies, such as the FDA's EUA stream, but pragmatic solutions must be found to facilitate wide-scale, independent evaluation of emerging tests."}

{"project":"LitCovid-sentences","denotations":[{"id":"T188","span":{"begin":0,"end":171},"obj":"Sentence"},{"id":"T189","span":{"begin":172,"end":388},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Critical considerations for diagnostics used for epidemic diseases of public health importance include the quality assurance and regulatory frameworks surrounding testing. Mature regulatory agencies have developed mechanisms to account for emergencies, such as the FDA's EUA stream, but pragmatic solutions must be found to facilitate wide-scale, independent evaluation of emerging tests."}